Page last updated: 2024-12-10

persin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

persin: isolated from the leaves of avocado (Persea americana); structure given in first source; RN given refers to compound with no isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5283266
CHEBI ID168336
SCHEMBL ID897833
MeSH IDM0257892

Synonyms (16)

Synonym
60640-59-7
CHEBI:168336
[(12z,15z)-2-hydroxy-4-oxohenicosa-12,15-dienyl] acetate
1-acetoxy-2-hydroxy-12z,15z-heneicosadien-4-one
LMFA05000011
(z,z)-1-(acetoxy)-2-hydroxy-12,15-heneicosadien-4-one
1-acetoxy-2-hydroxy-heneicosa-12z,15z-dien-4-one
persin
1-acetyloxy-2-hydroxy-12,15-heneicosadien-4-one
12,15-heneicosadien-4-one, 1-(acetyloxy)-2-hydroxy-
(z,z)-1-acetyloxy-2-hydroxy-12,15-heneicosadien-4-one
SCHEMBL897833
2-hydroxy-4-oxo-12,15-heneicosadien-1-yl acetate
(z,z)-1-acetoxy-2-hydroxy-4-oxo-heneicosa-12,15-diene
Q633921
DTXSID601027122

Research Excerpts

Overview

Persin is a plant toxin that displays synergistic cytotoxicity with tamoxifen in human breast cancer cell lines. The PersIn framework is a proposed approach for personalizing an evidence-based intervention.

ExcerptReferenceRelevance
"The PersIn framework is a proposed approach for personalizing an evidence-based intervention to facilitate cultural responsiveness concurrent with fidelity to the original intervention, flexibility in individual implementation, and administration that is standardized, feasible, and replicable."( Personalizing PCIT for culturally diverse families: Outcomes from a pilot trial utilizing the PersIn framework.
McCabe, K; Yeh, M; Zerr, A, 2022
)
1.42
"Persin is a plant toxin that displays synergistic cytotoxicity with tamoxifen in human breast cancer cell lines. "( Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells.
Biden, TJ; Boslem, E; Burgess, A; Butt, AJ; Gee, JM; McCloy, RA; Musgrove, EA; Nicholson, RI; Roberts, CG; Shelley, EJ; Sutherland, RL, 2013
)
2.07

Effects

ExcerptReferenceRelevance
"Persin has previously been isolated from avocado leaves and shown to have antifungal properties and to be toxic to silkworms."( Isolation and identification of a compound from avocado (Persea americana) leaves which causes necrosis of the acinar epithelium of the lactating mammary gland and the myocardium.
MacLeod, JK; Ng, JC; Oelrichs, PB; Schäffeler, L; Seawright, AA; Ward, A, 1995
)
1.01
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
long-chain fatty alcoholA fatty alcohol with a chain length ranging from C13 to C22.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's2 (18.18)29.6817
2010's5 (45.45)24.3611
2020's3 (27.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 70.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index70.10 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index112.90 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (70.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]